Expression of MAGE-1, -2 and -3 genes in primary and metastatic lesions of human malignant melanomas

Croatian Medical Journal

Volumn 37, Issue 2, 1996, Pages 119-122

  Juretić, Antonio ^a   Knežević, Fabijan ^a   Spagnoli, Giulio C ^b   Jürgens Göbel, Jutta ^b   Šamija, Mirko ^a   Herceg, Tonko ^a   Šeparović, Viktor ^a   Eljuga, Damir ^a   Turić, Marko ^a   Heberer, Michael ^b  

^a SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Chromosomal proteins, gene expression; Gene frequency; Melanoma; Transcription factors

Indexed keywords

CHROMOSOME PROTEIN; MELANOMA ANTIGEN; TRANSCRIPTION FACTOR;

ARTICLE; CONTROLLED STUDY; CYTOTOXIC LYMPHOCYTE; GENE EXPRESSION; GENE FREQUENCY; HUMAN; HUMAN TISSUE; MELANOMA; METASTASIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 9344271111     PISSN: 03539504     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Boon T, Cerottini JC. Tumor antigens recognized by T lymphocytes. Annu Rev Immunol 1994;12:337-65.
2. Roth C, Rochlitz C, Kourilsky P. Immune response against tumors. Adv Immunol 1994;57:281-351.
3. van Pel A, van der Bruggen P, Coulie PG, Brichard VG, Lethe B, van den Eynde B, et al. Genes coding for tumor antigens recognized by cytolytic T lymphocytes. Immunol Rev 1995;145:229-50.
4. Urban JL, Schreiber H. Tumor antiges. Annu Rev Immunol 1992;10:617-44.
5. van der Bruggen P, Traversari C, Chomes P, Lurquin E, de Plaen E, van den Eynde B, et al. A gene encoding an antigen recognized by cytolitic T lymphocytes on a human melanoma. Science 1991;254:1643-7.
6. Wölfel T, Schneider J, Meyer zum Büschnenfelde K, Rammensee H, Rötzschke O, Falk K. Isolation of naturally processed peptides recognized by cytolytic T lymphocytes (CTL) on human melanoma cells in association with HLA-A2.1. Int J Cancer 1995;57:413-8.
7. Slingluff CL Jr, Cox AL, Henderson RA, Hunt DF, Engelhard VH. Recognition of human melanoma cells by HLA-A2.1-restricted cytotoxic lymphocytes is mediated by at least six shared peptide epitopes. J Immunol 1993;150:2955-63.
8. O'Neil BH, Kawakami Y, Restifo NP, Bennink JR, Yewdel JW, Rosenberg SA. Detection of shared MHC-restricted human melanoma antigens after vaccinia virus-mediated transduction of genes coding for HLA. J Immunol 1993;151:1410-8.
9. van Pel A, Coulie PG. Defined antigens recognized by T lymphocytes on human tumors. Curr Opin Oncol 1993;5:1043-8.
10. Brasseur F, Marchand M, Vanwijck R, Herin M, Lethe B, Chomes P, et al. Human gene MAGE-1, which codes for a tumor-rejection antigen, is expressed by some breast tumors. Int J Cancer 1992;52:839-41.
11. de Smet C, Lurquin C, van der Bruggen P, de Plaen E, Brasseur F, Boon T. Sequence and expression pattern of the human MAGE2 gene. Immunogenetics 1994;39: 121-9.
12. Gaugler B, van den Eynde B, van der Bruggen P, Romero P, Gaforio JJ, de Plaen E, et al. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J Exp Med 1994;179:921-30.
13. Inou H, Li J, Honda M, Nakashima H, Shibuta K, Arinaga S, et al. MAGE-1 mRNA expression in gastric carcinoma. Int J Cancer 1995;64:76-7.
14. Patard J, Brasseur F, Gil-Diez S, Radvanyi F, Marchand M, Francois P, et al. Expression of MAGE genes in transitional-cell carcinoma of the urinary bladder. Int J Cancer 1995;64:60-4.
15. Rimoldi D, Romero P, Carrel S. The human melanoma antigen-encoding gene, MAGE-1, is expressed by other tumour cells of neuroectodermal origin such as glioblastomas and neuroblastomas. Int J Cancer 1993; 54:527-8.
16. Brasseur F, Rimoldi D, Lienard D, Lethe B, Carrel S, Arienti F, et al. Expression of MAGE genes in primary and metastatic cutaneous melanoma. Int J Cancer 1995;63:375-80.
17. Russo V, Traversari C, Verrecchia A, Mottolese M, Natali PG, Bordignon C. Expression of the MAGE gene family in primary and metastatic human breast cancer: implications for tumor antigen-specific immunotherapy. Int J cancer 1995;64:216-21.
18. Lüscher U, Filgueira L, Juretic A, Zuber M, Lüscher NJ, Heberer M, et al. The pattern of cytokine gene expression in freshly excised human metastatic melanoma suggests a state of reversible anergy of tumor-infiltrating lymphocytes. Int JCancer 1994;57:612-9.
19. Juretic A, Spagnoli CG, Hoerig H, Shipman R, Kocher T, Samija M, et al. Tyrosine kinase-dependent and -independent events induced by interleukin-2 stimulation: interleukin-2 mediated NO production required for the induction of lymphokine-activated killer cell activity in rat splenocytes is tyrosine kinase independent. Immunology 1995;85:325-30.
20. Kocher T, Schultz-Thater E, Gudat F, Schaefer C, Casorati G, Juretic A, et al. Identification and intracellular location of MAGE-3 gene products. Cancer Res 1995;55:2236-9.
21. Chomczynski P, Sacchi N. Single-step method of RNA isolation by guanidinium thocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
22. Nakajima-Iijima S, Hamada H, Reddy P, Kakunaga T. Molecular structure of the human cytoplasmic beta-acthi gene: interspecies homology of sequences introns. Proc Natl Acad Sci U S A 1995;82:6133-7.
23. Boon T. Tumor antigens recognized by cytolytic T lymphocytes: present perspectives for specific immunotherapy. Int J Cancer 1993;54:177-80.
24. Melief CJM, Kast MW. T-cell immunotherapy of tumors by adoptive transfer of cytotoxic T lymphocytes and by vaccination with minimal essential epitopes. Immunol Rev 1995;145:167-77.
25. Cheever MA, Disis ML, Bernhard H, Gralow JR, Hand SL, Huseby ES, et al. Immunity to oncogenic proteins. Immunol Rev 1995;145:33-59.
26. Oaks MK, Hanson JP, O'Malley DP. Molecular cytogenetic mapping of the human melanoma antigen (MAGE) gene family to chromosome region Xq27-qter: implication for MAGE immunotherapy. Cancer Res 1994;54:1627-9.
27. Schultz-Thater E, Juretic A, Dellabona P, Luecher U, Siegrist W, Harder F, et al. MAGE-1 gene product is a cytoplasmic protein. Int J Cancer 1994;59:435-9.
28. Jardetsky TS, Lane WS, Robinson RA, Madden DR, Wiley DC. Identification of self peptides bound to purified HLA-B27. Nature 1991;353:326-9.